APPENDIX 1.

Extrarenal manifestations by systems in all 212 patients at baseline visit and end of study.

SLEDAI-2K Organ SystemsAll Patients, Start of Study, n (%)All Patients, End of Study, n (%)
CNS27 (12.7)12 (5.7)
Vascular20 (9.4)6 (2.8)
Musculoskeletal21 (9.9)4 (1.9)
Serosal21 (9.9)4 (1.9)
Dermal81 (38.2)51 (24.1)
Immunologic174 (82.5)130 (61.6)
Constitutional27 (12.8)10 (4.7)
Hematologic9 (4.3)9 (4.3)
  • SLEDAI-2K: Systemic Lupus Erythematosus Disease Activity Index-2000; CNS: central nervous system.